Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vinicius Renan Pinto de Mattos

Successful Treatment of Post-Transplant Relapsed Acute Myeloid Leukemia With FLT3 Internal Tandem Duplication Using the Combination of Induction Chemotherapy, Donor Lymphocyte Infusion, Sorafenib and Azacitidine. Report of Three Cases

Einstein (São Paulo, Brazil)

Medicine

2017

English

Related publications

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

English

Improved FLT3 Internal Tandem Duplication PCR Assay Predicts Outcome After Allogeneic Transplant for Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Flt3 Internal Tandem Duplication and P-Glycoprotein Functionality in 171 Patients With Acute Myeloid Leukemia

Clinical Cancer Research

Cancer Research

Oncology

2006

English

Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia

English

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

English

Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion

English

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vinicius Renan Pinto de Mattos

Successful Treatment of Post-Transplant Relapsed Acute Myeloid Leukemia With FLT3 Internal Tandem Duplication Using the Combination of Induction Chemotherapy, Donor Lymphocyte Infusion, Sorafenib and Azacitidine. Report of Three Cases

Related publications

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Improved FLT3 Internal Tandem Duplication PCR Assay Predicts Outcome After Allogeneic Transplant for Acute Myeloid Leukemia

Flt3 Internal Tandem Duplication and P-Glycoprotein Functionality in 171 Patients With Acute Myeloid Leukemia

Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia